Stomach Neoplasms: all 2,914 studies
Page 4 of 30. Open to participants first (881), then studies with results posted, then the rest; newest registration first within each.
- Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Gastric CancerRecruitingNCT06979895
- The Application Value of Spectral CT in the Accurate Staging of Gastric CancerNot yet recruitingNCT06977386Not applicable
- Efficacy and Safety of Fruquintinib Combined With Sintilimab and Stereotactic Body Radiation Therapy (SBRT) for the Second-line and Higher-line Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma With Oligometastatic ProgressionNot yet recruitingNCT06977061Phase 2/3
- Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid TumorsRecruitingNCT06974110Phase 1
- Artificial Intelligence to Solve the MissINg of Gastric Cancer (AIMING)Not yet recruitingNCT06971471Not applicable
- Reconstruction With a Lawrence-Hunt Jejunal Pouch After Total GastrectomyRecruitingNCT06967571Not applicable
- A Randomized Controlled Study of Endoscopic Cryoablation Combined With PD-1 Inhibitor for Maintenance Therapy in Advanced Gastric CancerNot yet recruitingNCT06957977Phase 2
- AI-Based Prediction of Lymph Node Metastasis in Gastric Cancer Using Preoperative Multimodal DataEnrolling by invitationNCT06957678
- Neoadjuvant Cadonilimab Combined With Perioperative Oxaliplatin Plus S1 for Diffuse or Mixed Type of Locally Advanced Gastric/Gastroesophageal Junction AdenocarcinomaRecruitingNCT06949033Phase 3
- Radiomics-Based AI Model for Predicting Para-Aortic Lymph Node Metastasis in Gastric Cancer PatientsEnrolling by invitationNCT06947096
- Clinical Outcomes of Indocyanine Green Tracer Using in Laparoscopic Gastrectomy With Extended Lymphadenectomy Beyond D2 for Locally Advanced Gastric Cancer (FUGES-30)RecruitingNCT06945718
- A Study of Disitamab Vedotin Combined With Tislelizumab and Chemotherapy Versus Tislelizumab Combined With Chemotherapy in HER2-Low Advanced Gastric or Gastroesophageal Junction AdenocarcinomaNot yet recruitingNCT06944496Phase 3
- Prospective Gastric Cancer Screening With Fecal Multi-target DNA AnalysisRecruitingNCT06943807
- Eradication of Helicobacter Pylori Subtypes at High Gastric Cancer Risk: a Cluster-randomized Controlled TrialNot yet recruitingNCT06943794Not applicable
- Fecal DNA Methylation and Helicobacter Pylori Gastric Cancer Susceptibility Genes TestNot yet recruitingNCT06943768
- A Study of MT-4561 in Patients With Various Advanced Solid TumorsRecruitingNCT06943521Phase 1/2
- Randomized Phase II Trial Evaluating DFS in The Absence of an Adjuvant Component of Perioperative Chemotherapy in Patients With Gastric CancerNot yet recruitingNCT06942663Phase 2
- CDH17 CAR-T Therapy in Advanced Malignant Solid TumorsRecruitingNCT06937567Early Phase 1
- Clinical Study of Double-Endoscopic Combined With Minimally Invasive Treatment for Early Gastric Cancer at Clinical Stage T1bNot yet recruitingNCT06934824Not applicable
- The Effect of Different Digestive Tract Reconstruction Methods on Postoperative Quality of Life After Proximal GastrectomyRecruitingNCT06929949
- Neoadjuvant Apatinib Combined With Sintilimab and Perioperative SOX Versus Neoadjuvant Sintilimab Combined With Perioperative SOX for Intestinal Type of Locally Advanced Gastric/Gastroesophageal Junction AdenocarcinomaRecruitingNCT06925243Phase 3
- Gastric Cancer' Textbook Oncological Outcome and Tumor Board PerformanceRecruitingNCT06923449
- Association of Nutritional Status With Immune Checkpoint Inhibitor Efficacy in Metastatic Metastatic Esophagogastric Cancer.Enrolling by invitationNCT06923020
- A First-in-Human Study Using BDC-4182 as a Single Agent in Advanced Gastric and Gastroesophageal CancerRecruitingNCT06921837Phase 1/2
- Metabolomic and Lipidomic Analysis Predicts Immunotherapy-related Adverse Events in Gastric Cancer PatientsRecruitingNCT06915389
- IDOV-Immune for Advanced Solid TumorsRecruitingNCT06910657Phase 1
- Ovarian-Sparing Adaptive Radiotherapy in Young Adult WomenRecruitingNCT06904365
- An Observational Study for Gastric Cancer in Carriers of High Risk Helicobacter PyloriRecruitingNCT06896370
- Robotic Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant TherapyRecruitingNCT06895447Phase 2
- ctDNA-MRD Monitoring After Resection in Gastric CancerRecruitingNCT06893133
- Application of Indocyanine Green Tracer in D2 Lymphadenectomy of Locally Advanced Gastric CancerNot yet recruitingNCT06892392Not applicable
- Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including MesotheliomaRecruitingNCT06885697Phase 1
- Establishment of Precision Targeted Therapy Strategies for Advanced Gastric Cancer Based on Novel Molecular SubtypingNot yet recruitingNCT06881017Phase 2
- SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid TumorsRecruitingNCT06873659Phase 1
- Fruquintinib Combined With PD-1 Inhibitor and FOLFOX as First-Line Treatment For Advanced Gastric CancerNot yet recruitingNCT06871527Phase 1/2
- Energy CT in Imaging and Diagnosis of Gastric CancerRecruitingNCT06869694
- Luso-Cor Stent Compared to Other Endoscopic Techniques for Management of Fistulas and Anastomotic Dehiscences(ES-LCCE-UDFM)Enrolling by invitationNCT06862479
- Development of a Predictive Model for Gastric Cancer Peritoneal Metastasis and Cachexia Using BUB1 and Radiopathomics Data With Deep LearningNot yet recruitingNCT06858644
- Capsule Gastric Endoscopy for Gastric Disease Screening in Simulated Home ScenariosRecruitingNCT06848400Not applicable
- Comparison of Full Robotic Instrumentation and Assistant-Controlled Laparoscopic Instrumentation in Robotic Distal GastrectomyRecruitingNCT06841484Not applicable
- Nanocrystalline Megestrol for First-line Treatment of Advanced Gastric or Colorectal Cancer With Cancer-related FatigueRecruitingNCT06830018Not applicable
- Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted TherapyRecruitingNCT06828588Early Phase 1
- Safety and Efficacy Study of Sorbitol With Neoadjuvant Chemotherapy Combined With Tirellizumab (PD-1 Inhibitor) in Patients With Locally Advanced Gastric CancerRecruitingNCT06826079Phase 2
- Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early DiagnosisRecruitingNCT06822413
- Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid TumorsRecruitingNCT06821048Phase 1
- Immune Checkpoint Inhibitors (ICIs) Retreatment in Second-line Treatment of Advanced Gastric Cancer: a Retrospective, Real-world StudyNot yet recruitingNCT06814548
- COMBO Endoscopy Oropharyngeal Airway Reduces Hypoxia During Sedated Gastrointestinal Endoscopy in Obese Patients: A Multicenter, Randomized, Controlled Clinical TrialRecruitingNCT06796764Not applicable
- Tislelizumab Plus FOLFOX Versus POF in the Treatment of Locally Advanced: a Multicenter, Open-label, Randomized Phase III Studyunresectable or Metastatic Gastric/Gastroesophageal Junction AdenocarcinomaRecruitingNCT06793917Phase 3
- PD-1 Antibody Carilizumab Combined with Apatinib for Unresectable Stage III and IV DMMR Gastric CancerRecruitingNCT06792162Phase 2
- Prediction of Drug Response in Gastric Cancer Based on 3D BioprintingRecruitingNCT06792149
- Robotic Versus Laparoscopic Radical Surgery for Locally Advanced Gastric CancerRecruitingNCT06791538Not applicable
- Low-dose Radiotherapy Combined With Chemotherapy and AK112 as Second-line Treatment in Patients With Advanced G/GEJ CancerRecruitingNCT06791148Phase 2
- Clinical Study of Envafolimab Combined With Fruquintinib and Chemotherapy for Neoadjuvant Treatment of Gastric CancerRecruitingNCT06791083Phase 2
- A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid TumorsRecruitingNCT06789172Phase 1
- Fluorescence Guided Laparoscopic-Endoscopic Cooperative Sentinel Lymph Node Navigation Surgery Strategy for Early Gastric Cancer（IDEAL Stage 2b）RecruitingNCT06788548Not applicable
- The Relationship of Psychological Stress With Therapy Efficacy and Prognosis of Gastric CancerRecruitingNCT06786169
- Differences in Gastric Microbiota in Patients Who Were Infected Between CagA Positive and Negative Helicobacter PyloriEnrolling by invitationNCT06785922Not applicable
- Preventive Use of PIPAC in Locally Advanced Gastric Cancer.RecruitingNCT06784765Not applicable
- A First-in-Human Escalation and Expansion Study of Patients With Advanced Solid TumorsRecruitingNCT06783569Phase 1
- Use of Pyrvinium to Reverse Stomach Precancerous ConditionsNot yet recruitingNCT06782048Phase 2
- Ropivacaine-Poloxamer 407 Gel for Pain Control After Open GastrectomyRecruitingNCT06778954Not applicable
- Screening of Small Non-coding RNAs as an Auxiliary Diagnostic Biomarker for Gastric CancerEnrolling by invitationNCT06776835
- A Phase Ib/II Study of Adebrelimab in Combination with Capecitabine and Oxaliplatin in CancerRecruitingNCT06776770Phase 1/2
- BC001 in Combination with Sintilimab and XELOX in the Treatment of HER-2 Negative Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma.RecruitingNCT06773312Phase 1
- HS-10502 Combination Treatment in Patients With Advanced Solid TumorsRecruitingNCT06769425Phase 1
- Cytoreductive Gastrectomy After Systemic Therapy Versus Systemic Therapy Alone For Limited Metastasis Gastric CancerRecruitingNCT06768463Not applicable
- Quality of Life After Billroth II or Roux-en-Y for Gastric CancerRecruitingNCT06768164Phase 3
- Zolbetuximab Claudin18.2 Positive, HER2 Negative, Advanced Gastric CancerRecruitingNCT06767449
- A Multi-center Real-world Efficacy and Safety of Trastuzumab-deruxtecan in Advanced Gastric CancerRecruitingNCT06767436
- QL1706 Combined With SOX Used in Theperioperative TreatmentRecruitingNCT06766305Phase 1/2
- A Prospective Cohort Study on the Treatment of Locally Advanced Gastric CancerRecruitingNCT06760858
- A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)RecruitingNCT06760819Phase 2
- Endoscopic Cryoablation Combined With PD-1 in Advanced Gastric CancerNot yet recruitingNCT06759233Phase 2
- Intraperitoneal Immune Checkpoint Inhibitors and Zoledronic Acids for Gastric Cancer Malignant AscitesRecruitingNCT06759064Phase 1/2
- Investigation of Impact of Indocyanine Green on Volume of Lymphadenectomy in Resectable Gastric CancerRecruitingNCT06755554Phase 3
- Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid TumorsRecruitingNCT06750185Phase 1/2
- Comparing the Efficacy of Sintilimab Plus Nab-POF Regimen, Sintilimab Plus XELOX Chemotherapy, and Lenvatinib, Sintilimab Plus XELOX Chemotherapy in the Treatment of HER2-negative, Metastatic Gastric CancerNot yet recruitingNCT06748508Phase 2
- Safety and Efficacy of Traction Robot-assisted Endoscopic Submucosal Dissection for Early Gastric CancerRecruitingNCT06748352Not applicable
- XELOX Combined With Sintilimab and HBO for Advanced or Metastatic GC/GEJCRecruitingNCT06742411Phase 1/2
- Preliminary Efficacy Analysis of "C" Single Flap Plasty Reconstruction After Laparoscopic Proximal GastrectomyNot yet recruitingNCT06741501Not applicable
- Exploration of Lymph Node Metastasis and Tumor Deposit in the Posterior Gastric Mesentery for Distal Gastric CancerRecruitingNCT06736847
- Study on the Value of Three DWI Scanning Sequences in Staging of Gastric CancerRecruitingNCT06735105Not applicable
- A Phase Ib/II Trial of Neoadjuvant Zolbetuximab Plus Docetaxel, Oxaliplatin and S-1 Chemotherapy in Patients With Locally Advanced Gastric CancerRecruitingNCT06732856Phase 1/2
- Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction CancerRecruitingNCT06731478Phase 3
- Utidelone Capsule Monotherapy for Patients with Advanced Solid TumorsNot yet recruitingNCT06730581Phase 2
- First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2)RecruitingNCT06730373Phase 2
- Analysis of Tumor Deposit at the Fusion Site of the Right Gastric Mesentery and Left Gastric Mesentery in the Patients With Gastric Cancer Who Received Proximal GastrectomyRecruitingNCT06728891
- Analysis of Lymph Node Metastasis and Tumor Deposit in the Short Gastric Mesentery Following Total Gastrectomy for Gastric CancerRecruitingNCT06728878
- First-Line and Neoadjuvant Immunotherapy for Gastric CancerRecruitingNCT06727981
- CfDNA in Hereditary And High-risk Malignancies 2RecruitingNCT06726642
- Target-specific immunoPET Imaging of Digestive System CarcinomaRecruitingNCT06715839Not applicable
- Vocorder Device Validation in Clinical Settings - Continuous Monitoring of Individuals (Vocorder Clinical Validation-VCV)Not yet recruitingNCT06711939
- Trifluridine/tipiracil (TAS-102), Bevacizumab, and Camrelizumab As Third-line or Later-line Therapy of Gastric CancerRecruitingNCT06711471Phase 2
- Lead-212 PSV359 Therapy for Patients With Solid TumorsRecruitingNCT06710756Phase 1/2
- A Metabolomics-based Study to Explore the Mechanism of Remission of Metabolic Syndrome After Radical GastrectomyEnrolling by invitationNCT06707714
- A Single-arm, Single-center Phase II Clinical Study on the Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection Combined With Fruquintinib Capsules in the Second-line Treatment of Patients With Advanced Gastric CancerNot yet recruitingNCT06706895Phase 2
- The Correlation Between Blood Concentration of Sintilimab and Efficacy and Adverse Reactions in Patients with Advanced Gastric CancerRecruitingNCT06702683
- Liposomal Irinotecan Combined with Sintilimab for Second-line Treatment of Progressive Gastric CancerNot yet recruitingNCT06697366Phase 2
- A Phase 2 Study of Zanidatamab in Patients With HER2-expressing TumorsRecruitingNCT06695845Phase 2
- Pilot Study for High Output Drainage Removal After GastrectomyRecruitingNCT06690112Not applicable